Why these 4 ASX shares are ending the week with BIG declines

The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is on course to have a disappointing end to the week. In afternoon trade the index is down 0.8% to 5,829 points.

Four shares which have acted as a major drag on the market today are listed below. Here’s why they are ending the week deep in the red:

The Bapcor Ltd (ASX: BAP) share price has fallen 4.5% to $5.23 despite there being no news out of the automotive aftermarket parts retailer. A good number of retail shares have fallen lower this week following weaker-than-expected Australian retail sales data.

The BT Investment Management Ltd (ASX: BTT) share price has sunk lower again, this time by 3.5% to $11.81. BTIM’s shares fell sharply yesterday following the release of a disappointing half-year result. This led to Macquarie downgrading its shares to a neutral rating with an $11.70 price target this morning. I would have to agree with Macquarie on this one.

The Japara Healthcare Ltd (ASX: JHC) share price has tumbled 4% to $2.15 even though there was no news out of the aged care operator. Japara isn’t the only aged care operator to fall lower today, rivals Estia Health Ltd (ASX: EHE) and Regis Healthcare Ltd (ASX: REG) are also in the red following a broad sector sell-off. I feel Japara could be reasonably good value now.

The Monash IVF Group Ltd (ASX: MVF) share price has dropped 4% to $1.99 after the leading fertility company announced the surprise resignation of its CEO. Although a change at the top can be disruptive, I feel confident that the company will be able to transition successfully and continue its solid growth.

If your portfolio suffered from these declines I wouldn't worry. These high-quality shares could be just what you need to take it to the next level.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks means stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

If you're expecting to see the likes of Commonwealth Bank, Telstra and Wesfarmers shares on this list, you'll be sorely disappointed. Not only are their dividends growing at a snail's pace, their profits are under pressure too due to the increasing competitive environment.

The contrast to these "new breed" blue chips couldn't be greater... especially the very real prospect of significant share price gains, something that's looking less likely from the usual blue chip suspects.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia owns shares of Bapcor. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.